Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzanne Craft

Showing results (151-160 of 243) with videos related to

Pageof 25
Sort By:
Archives of Neurology|September 14, 2011
Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trialSuzanne Craft, Laura D Baker, Thomas J Montine, et al.
Nature Reviews. Neurology|January 30, 2018
Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrumsSteven E Arnold, Zoe Arvanitakis, Shannon L Macauley-Rambach, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Evaluation of plasma p-tau217 for detecting amyloid pathology in a diverse and heterogeneous community-based cohortMarc D Rudolph, Courtney L Sutphen, Thomas C Register, et al.
Molecular Biology Reports|April 21, 2021
Effect of ethanol and cocaine on [<sup>11</sup>C]MPC-6827 uptake in SH-SY5Y cellsNaresh Damuka, Miranda Orr, Paul W Czoty, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 9, 2025
Impact of neighborhood disadvantage on cardiometabolic health and cognition in a community-dwelling cohortSudarshan Krishnamurthy, Lingyi Lu, Christian J Johnson, et al.
Alzheimer'S Research & Therapy|May 24, 2026
Uncovering lipid biomarkers linked to methylphenidate efficacy in treating apathy in Alzheimer's disease: insights from the ADMET 2 trialMyuri Ruthirakuhan, Maya Mills, Paul Rosenberg, et al.
The New England Journal of Medicine|August 9, 2013
Glucose levels and risk of dementiaPaul K Crane, Rod Walker, Rebecca A Hubbard, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 23, 2022
Blood-based bioenergetic profiling reveals differences in mitochondrial function associated with cognitive performance and Alzheimer's diseaseGargi Mahapatra, Zhengrong Gao, James R Bateman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 21, 2026
Evaluation of an in vivo biomarker of arteriolosclerosis (ARTS) and its associations with cognition and multimodal ATN(V) biomarkers in a cardiometabolic-risk enriched community cohortMarc D Rudolph, Samuel N Lockhart, Melissa R Rundle, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 15, 2024
Associations among plasma, MRI, and amyloid PET biomarkers of Alzheimer's disease and related dementias and the impact of health-related comorbidities in a community-dwelling cohortMarc D Rudolph, Courtney L Sutphen, Thomas C Register, et al.
Pageof 25

Showing results (151-160 of 243) with videos related to

Sort By:
Pageof 25
Archives of Neurology|September 14, 2011
Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trialSuzanne Craft, Laura D Baker, Thomas J Montine, et al.
Nature Reviews. Neurology|January 30, 2018
Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrumsSteven E Arnold, Zoe Arvanitakis, Shannon L Macauley-Rambach, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Evaluation of plasma p-tau217 for detecting amyloid pathology in a diverse and heterogeneous community-based cohortMarc D Rudolph, Courtney L Sutphen, Thomas C Register, et al.
Molecular Biology Reports|April 21, 2021
Effect of ethanol and cocaine on [<sup>11</sup>C]MPC-6827 uptake in SH-SY5Y cellsNaresh Damuka, Miranda Orr, Paul W Czoty, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 9, 2025
Impact of neighborhood disadvantage on cardiometabolic health and cognition in a community-dwelling cohortSudarshan Krishnamurthy, Lingyi Lu, Christian J Johnson, et al.
Alzheimer'S Research & Therapy|May 24, 2026
Uncovering lipid biomarkers linked to methylphenidate efficacy in treating apathy in Alzheimer's disease: insights from the ADMET 2 trialMyuri Ruthirakuhan, Maya Mills, Paul Rosenberg, et al.
The New England Journal of Medicine|August 9, 2013
Glucose levels and risk of dementiaPaul K Crane, Rod Walker, Rebecca A Hubbard, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 23, 2022
Blood-based bioenergetic profiling reveals differences in mitochondrial function associated with cognitive performance and Alzheimer's diseaseGargi Mahapatra, Zhengrong Gao, James R Bateman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 21, 2026
Evaluation of an in vivo biomarker of arteriolosclerosis (ARTS) and its associations with cognition and multimodal ATN(V) biomarkers in a cardiometabolic-risk enriched community cohortMarc D Rudolph, Samuel N Lockhart, Melissa R Rundle, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 15, 2024
Associations among plasma, MRI, and amyloid PET biomarkers of Alzheimer's disease and related dementias and the impact of health-related comorbidities in a community-dwelling cohortMarc D Rudolph, Courtney L Sutphen, Thomas C Register, et al.
Pageof 25